$3.02 $0.12 (4.1%)

04:00 PM EDT on 07/19/19

Rockwell Medical Tech (NASDAQ:RMTI)

CAPS Rating: 1 out of 5

The Company manufactures, sells and distributes hemodialysis concentrates and other ancillary medical products and supplies used in the treatment of patients with End Stage Renal Disease.

Current Price $3.02 Mkt Cap $270.1M
Open $2.90 P/E Ratio 0.00
Prev. Close $2.90 Div. (Yield) $0.00 (0.0%)
Daily Range $2.76 - $3.05 Volume 186,390
52-Wk Range $2.20 - $6.88 Avg. Daily Vol.

Caps

How do you think NASDAQ:RMTI will perform against the market?

Add Stock to CAPS Watchlist

All Players

85 Outperform
19 Underperform
 

All-Star Players

9 Outperform
11 Underperform
 

Wall Street

6 Outperform
2 Underperform
 

Top NASDAQ:RMTI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TaylorStroh (67.76)
Submitted July 15, 2009

Here is a stock that I own and have watched for a couple years now, Rockwell Medical Technologies, I have wanted to have it on CAPS since I started but alas its not big enough...yet. I will give this to you as quickly as I can, they are in the… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:RMTI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about RMTI.

Recs

0
Member Avatar TerryHogan (99.97) Submitted: 12/4/2018 1:52:51 AM : Underperform Start Price: $3.13 NASDAQ:RMTI Score: +10.30

This company shows no signs of ever making decent margins, let alone eke out a profit. Lots of dilution here, and no actual cash flow. Market cap is far too high for the potential here.

Recs

0
Member Avatar LifeScientist (22.93) Submitted: 3/2/2016 7:49:25 PM : Outperform Start Price: $6.11 NASDAQ:RMTI Score: -100.10

watch

Recs

0
Member Avatar jtmeltzer (< 20) Submitted: 7/13/2015 9:35:54 PM : Outperform Start Price: $18.00 NASDAQ:RMTI Score: -124.96

The company is the #2 provider of hemodialysis solutions in the US. They are currently going to launch the only FDA approved iron therapy to treat kidney failure patients. This may save the hemodialysis providers millions in savings as they will need to buy less Epogen. These providers get paid per hemodialysis session - so anyway to reduce expenditures is their only way to improve margins. This stock is about to breakthrough $18 resistance. Don't wait for a pullback.

Leaderboard

Find the members with the highest scoring picks in RMTI.

Score Leader

GoldenPhrogcom

GoldenPhrogcom (< 20) Score: +324.98

The Score Leader is the player with the highest score across all their picks in RMTI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
3004pawel 37.37 1/21/2010 Underperform 3W $7.28 -58.52% +160.93% +219.45 0 Comment
shorttest4 32.91 3/8/2010 Underperform 5Y $6.28 -51.91% +160.15% +212.06 0 Comment
jroren 99.13 6/21/2010 Underperform 3M $4.58 -34.06% +162.77% +196.84 0 Comment
epsdecreases 56.33 10/31/2012 Underperform 5Y $7.40 -59.19% +109.55% +168.74 0 Comment
kevrose31 78.15 1/10/2014 Underperform 1Y $10.52 -71.29% +61.59% +132.89 0 Comment
donp8 < 20 5/19/2014 Underperform 3W $9.97 -69.71% +58.37% +128.08 1 Comment
icebit1 57.80 11/4/2014 Underperform 5Y $9.69 -68.82% +47.78% +116.59 0 Comment
VeryShiny < 20 3/19/2013 Underperform 3M $3.69 -18.16% +92.97% +111.13 0 Comment
JCLscapXperiment 98.55 12/15/2014 Underperform 5Y $8.33 -63.75% +47.17% +110.91 1 Comment
rothenbr 80.62 8/22/2016 Underperform 3Y $7.24 -58.29% +36.19% +94.48 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.23 1/30/2015 Underperform 3W $10.79 -72.01% +49.03% +121.05 0 Comment
trackchardan 74.16 12/19/2013 Outperform NS $10.91 -72.32% +64.05% -136.37 0 Comment
TrackBreanMurray 24.29 12/17/2013 Underperform NS $10.65 -71.64% +65.73% +137.37 0 Comment
tracksummerstree 82.58 4/11/2012 Outperform NS $9.47 -68.11% +116.34% -184.45 0 Comment
TrackStifel 91.05 3/12/2012 Outperform NS $9.37 -67.77% +116.10% -183.87 0 Comment
TrackCanaccord 65.71 1/3/2012 Outperform NS $8.84 -65.84% +132.66% -198.50 0 Comment
TrackJMP 84.20 3/4/2010 Outperform NS $6.31 -52.14% +164.34% -216.48 0 Comment
TrackWedbush 88.25 10/12/2009 Outperform NS $7.80 -61.28% +176.67% -237.95 0 Comment

Advertisement